Page last updated: 2024-11-03

pyrimethamine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

pyrimethamine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Maloprim: contains above 2 cpds

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jung, YY1
Kim, C1
Ha, IJ1
Lee, SG1
Lee, J1
Um, JY1
Ahn, KS1
Palkovacs, EM1
Correa, Z1
Augsburger, JJ1
Eagle, RC1

Other Studies

2 other studies available for pyrimethamine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Pyrimethamine Modulates Interplay between Apoptosis and Autophagy in Chronic Myelogenous Leukemia Cells.
    International journal of molecular sciences, 2021, Jul-29, Volume: 22, Issue:15

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein 7; Beclin-1; Cell Proliferati

2021
Acquired toxoplasmic retinitis in an immunosuppressed patient: diagnosis by transvitreal fine-needle aspiration biopsy.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:10

    Topics: Adult; Antiprotozoal Agents; Biopsy, Fine-Needle; Bone Marrow Transplantation; Drug Therapy, Combina

2008